Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs

European Journal of Pharmaceutical Sciences

Volumn 46, Issue 5, 2012, Pages 367-373

  Rozehnal, Veronika ^a   Nakai, Daisuke ^a   Hoepner, Ursula ^a   Fischer, Thomas ^a   Kamiyama, Emi ^a   Takahashi, Masayuki ^a   Yasuda, Satoru ^a   Mueller, Juergen ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Apparent permeability coefficient; Fraction absorbed; Humane intestine; P glycoprotein; Ussing chamber

Indexed keywords

ATENOLOL; DIGOXIN; FAMOTIDINE; IBUPROFEN; LUCIFER YELLOW; METFORMIN; METOPROLOL; PARACETAMOL; PHENAZONE; PRAVASTATIN; SALAZOSULFAPYRIDINE; SULPIRIDE; VERAPAMIL;

ADULT; ARTICLE; COLON; DRUG ABSORPTION; FEMALE; GENERAL DEVICE; HUMAN; HUMAN TISSUE; HYDROPHILICITY; INTESTINE ABSORPTION; MALE; MOLECULAR WEIGHT; PERMEABILITY; PRIORITY JOURNAL; SMALL INTESTINE; USSING CHAMBER;

ADMINISTRATION, ORAL; COLON; DIFFUSION CHAMBERS, CULTURE; DRUG INTERACTIONS; FLUORESCENT DYES; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTESTINE, SMALL; ISOQUINOLINES; KINETICS; P-GLYCOPROTEIN; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; TISSUE SURVIVAL;

EID: 84861186211     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.02.025     Document Type: Article

References (38)

1. D.M. Albin, and K.A. Tappenden Advances in methods to evaluate gastrointestinal transport function Curr. Opin. Clin. Nutr. Metab. Care 4 2001 351 354
2. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification, the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
3. K. Arimori, and M. Nakano Drug exsorption from blood into the gastrointestinal tract Pharm. Res. 15 1998 371 376
4. P. Artursson, and J. Karlsson Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells Biochem. Biophys. Res. Commun. 175 1991 880 885
5. P. Artursson, A.L. Ungell, and J.E. Lofroth Selective paracellular permeability in two models of intestinal absorption, cultured monolayers of human intestinal epithelial cells and rat intestinal segments Pharm. Res. 10 1993 1123 1129
6. A. Avdeef, S. Bendels, L. Di, B. Faller, M. Kansy, K. Sugano, and Y. Yamauchi PAMPA-critical factors for better predictions of absorption J. Pharm. Sci. 96 2007 2893 2909
7. P.V. Balimane, and S. Chong Cell culture-based models for intestinal permeability, a critique Drug Discovery Today 10 2005 335 343
8. P.V. Balimane, Y.H. Han, and S. Chong Current industrial practices of assessing permeability and P-glycoprotein interaction AAPS J. 8 2006 E1 E13
9. L. Barthe, M. Bessouet, J.F. Woodley, and G. Houin The improved everted gut sac, a simple method to study intestinal P-glycoprotein Int. J. Pharm. 173 1998 255 258
10. J.M. Butler, and J.B. Dressman The developability classification system, application of biopharmaceutics concepts to formulation development J. Pharm. Sci. 99 2010 4940 4954
11. W.L. Chiou We may not measure the correct intestinal wall permeability coefficient of drugs, alternative absorptive clearance concept J. Pharmacokinet. Biopharm. 23 1995 323 331
12. J.M. Custodio, C.Y. Wu, and L.Z. Benet Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption Adv. Drug Deliv. Rev. 60 2008 717 733
13. L. Di, E.H. Kerns, K. Fan, O.J. McConnell, and G.T. Carter High throughput artificial membrane permeability assay for blood-brain barrier Eur. J. Med. Chem. 38 2003 223 232
14. G. Englund, F. Rorsman, A. Ronnblom, U. Karlbom, L. Lazorova, J. Grasjo, A. Kindmark, and P. Artursson Regional levels of drug transporters along the human intestinal tract, co-expression of ABC and SLC transporters and comparison with Caco-2 cells Eur. J. Pharm. Sci. 29 2006 269 277
15. FDA Guidance for Industry., 2000. Waiver of in vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. http://www.fda.gov/AnimalVeterinary/ GuidanceComplianceEnforcement/GuidanceforIndustry/default.htm.
16. M.P. Fink Intestinal epithelial hyperpermeability, update on the pathogenesis of gut mucosal barrier dysfunction in critical illness Curr. Opin. Crit. Care 9 2003 143 151
17. G.M. Grass, and P.J. Sinko Physiologically-based pharmacokinetic simulation modelling Adv. Drug Deliv. Rev. 54 2002 433 451
18. B. Greiner, M. Eichelbaum, P. Fritz, H.P. Kreichgauer, O. von Richter, J. Zundler, and H.K. Kroemer The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin J. Clin. Invest. 104 1999 147 153
19. I.S. Haslam, D.A. O'Reilly, D.J. Sherlock, A. Kauser, C. Womack, and T. Coleman Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue Biopharm. Drug Dispos. 32 2011 210 221
20. R. Hayeshi, C. Hilgendorf, P. Artursson, P. Augustijns, B. Brodin, P. Dehertogh, K. Fisher, L. Fossati, E. Hovenkamp, T. Korjamo, C. Masungi, N. Maubon, R. Mols, A. Mullertz, J. Monkkonen, C. O'Driscoll, H.M. Oppers-Tiemissen, E.G. Ragnarsson, M. Rooseboom, and A.L. Ungell Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories Eur. J. Pharm. Sci. 35 2008 383 396
21. E.H. Kerns, L. Di, S. Petusky, M. Farris, R. Ley, and P. Jupp Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery J. Pharm. Sci. 93 2004 1440 1453
22. K. Lee, C. Ng, K.l. Brouwer, and D.R. Thakker Secretory transport of ranitidine and famotidine across Caco-2 cell monolayers J. Pharmacol. Exp. Ther. 303 2002 574 580
23. H. Lennernas Human intestinal permeability J. Pharm. Sci. 87 1998 403 410
24. H. Lennernas, S. Nylander, and A.L. Ungell Jejunal permeability, a comparison between the Ussing chamber technique and the single-pass perfusion in humans Pharm. Res. 14 1997 667 671
25. M. Lindenberg, S. Kopp, and J.B. Dressman Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system Eur. J. Pharm. Biopharm. 58 2004 265 278
26. H. Mineo, H. Hara, N. Shigematsu, Y. Okuhara, and F. Tomita Melibiose, difructose anhydride III and difructose anhydride IV enhance net calcium absorption in rat small and large intestinal epithelium by increasing the passage of tight junctions in vitro J. Nutr. 132 2002 3394 3399
27. J.M. Mullin, M.C. Valenzano, J.J. Verrecchio, and R. Kothari Age- and diet-related increase in transepithelial colon permeability of Fischer 344 rats Dig. Dis. Sci. 47 2002 2262 2270
28. P. Nejdfors, M. Ekelund, B. Jeppsson, and B.R. Westrom Mucosal in vitro permeability in the intestinal tract of the pig, the rat, and man, species- and region-related differences Scand. J. Gastroenterol. 35 2000 501 507
29. R.L. Oostendorp, J.H. Beijnen, and J.H. Schellens The biological and clinical role of drug transporters at the intestinal barrier Cancer Treat. Rev. 35 2009 137 147
30. S. Oswald, B. Terhaag, and W. Siegmund In vivo probes of drug transport, commonly used probe drugs to assess function of intestinal P-glycoprotein (ABCB1) in humans Handb. Exp. Pharmacol. 2011 403 447
31. N. Parrott, and T. Lave Prediction of intestinal absorption, comparative assessment of GASTROPLUS and IDEA Eur. J. Pharm. Sci. 17 2002 51 61
32. C. Pauli-Magnus, O. von Richter, O. Burk, A. Ziegler, T. Mettang, M. Eichelbaum, and M.F. Fromm Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein J. Pharmacol. Exp. Ther. 293 2000 376 382
33. A.P. Soler, R.D. Miller, K.V. Laughlin, N.Z. Carp, D.M. Klurfeld, and J.M. Mullin Increased tight junctional permeability is associated with the development of colon cancer Carcinogenesis 20 1999 1425 1431
34. M. Takahashi, T. Washio, N. Suzuki, K. Igeta, Y. Fujii, M. Hayashi, Y. Shirasaka, and S. Yamashita Characterization of gastrointestinal drug absorption in cynomolgus monkeys Mol. Pharm. 5 2008 340 348
35. A.L. Ungell, S. Nylander, S. Bergstrand, A. Sjoberg, and H. Lennernas Membrane transport of drugs in different regions of the intestinal tract of the rat J. Pharm. Sci. 87 1998 360 366
36. C. Wallon, Y. Braaf, M. Wolving, G. Olaison, and J.D. Soderholm Endoscopic biopsies in Ussing chambers evaluated for studies of macromolecular permeability in the human colon Scand. J. Gastroenterol. 40 2005 586 595
37. S. Yee In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth Pharm. Res. 14 1997 763 766
38. Y.H. Zhao, J. Le, M.H. Abraham, A. Hersey, P.J. Eddershaw, C.N. Luscombe, D. Butina, G. Beck, B. Sherborne, I. Cooper, and J.A. Platts Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors J. Pharm. Sci. 90 2001 749 784